Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-18

Clinical Trial Update: Open Label Study Telmisartan and Amlodipine in Hypertension [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial evaluating the combination of telmisartan and amlodipine for hypertension, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micardis (telmisartan)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-01-18